Cancer epitope prediction tools and analysis pipelines in CEDAR
Nucleic Acids Research · 11.07.2026 · 54 (W1) · W13-W21
DOI: 10.1093/nar/gkag457 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 12.05.2026. Verfasst von Ibel Carri und 14 weiteren Autor:innen. Beteiligte Einrichtung: Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA 92037, United States. Hauptthemen laut MEDLINE: Software, Epitopes, T-Lymphocyte, Neoplasms, Epitopes. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Accurate identification of immunogenic cancer epitopes remains a central challenge in immuno-oncology. The Cancer Epitope Database and Analysis Resource (CEDAR, https://cedar.iedb.org/) was developed to provide comprehensive curation of experimentally validated epitopes and to foster the development of computational tools tailored to the cancer context. Recently, we released a suite of cancer-specific tools and analysis pipelines as part of the https://nextgen-tools.iedb.org/ platform, enabling users to generate, evaluate, and prioritize candidate T cell epitopes in a modular framework. Here, we present the design and functionality of these tools, describe their core methodologies, provide guidance for their use, and illustrate how they can be integrated into end-to-end pipelines. We highlight applications in cancer immunology and personalized immunotherapy by presenting practical use cases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA 92037, United States.
- Bioinformatics Core, La Jolla Institute for Immunology, La Jolla, CA 92037, United States.
- Department of Medicine, University of California, San Diego, La Jolla, CA 92093, United States.
- Department of Health Technology, Technical University of Denmark, Kgs, Lyngby DK-2800, Denmark.
ORCID-Profile: Ibel Carri, Jason Greenbaum, Hannah Carter, Ko-Han Lee, Morten Nielsen, Bjoern Peters, Zeynep Koşaloğlu-Yalçın
Förderung
- NCI NIH HHS
- NIH HHS
- National Institutes of Health
- National Cancer Institute
Zitieren
APA
Carri, I., Greenbaum, J., Yan, Z., Kim, K., Kim, H., Premlal, A. L. R., Marrama, D., Blazeska, N., Carter, H., Lee, K. H., Sears, T., Nielsen, M., Sette, A., Peters, B., & Koşaloğlu-Yalçın, Z. (2026). Cancer epitope prediction tools and analysis pipelines in CEDAR. Nucleic Acids Research, 54(W1), W13-W21. https://doi.org/10.1093/nar/gkag457
Vancouver
Carri I, Greenbaum J, Yan Z, Kim K, Kim H, Premlal ALR, et al. Cancer epitope prediction tools and analysis pipelines in CEDAR. Nucleic Acids Research. 2026;54(W1):W13-W21. doi:10.1093/nar/gkag457
BibTeX
@article{Carri2026,
author = {Carri, Ibel and Greenbaum, Jason and Yan, Zhen and Kim, Kevin and Kim, Haeuk and Premlal, Ashmitaa Logandha Ramamoorthy and Marrama, Daniel and Blazeska, Nina and Carter, Hannah and Lee, Ko-Han and Sears, Timothy and Nielsen, Morten and Sette, Alessandro and Peters, Bjoern and Koşaloğlu-Yalçın, Zeynep},
title = {Cancer epitope prediction tools and analysis pipelines in CEDAR},
journal = {Nucleic Acids Research},
year = {2026},
volume = {54},
number = {W1},
pages = {W13--W21},
doi = {10.1093/nar/gkag457}
}
EUVIMED